Trial Details

Not Recruiting
Basic Information
Clinical ID c2172
Identifier ChiCTR2300073537
Trial Title Application of active therapeutic drug monitoring of infliximab in pediatric inflammatory bowel disease
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions IBD
Interventions Active TDM:The treatment group adjusts the treatment plan based on IFX concentration;Control group:During the treatment period, there will be no monitoring of IFX blood drug concentration and ATI, and empirical medication adjustments will be made based on clinical, biochemical, endoscopic results.;
Participant Information
Sponsor Shengjing Hospital of CMU
City -
Country/Region China
Enrollment Criteria
Sex Requirement ALL
Age Requirement CHILD, TEENAGER
Study Design
Study Type Interventional study
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -